NCT00150527View on ClinicalTrials.gov

Specific Effects of Escitalopram on Neuroendocrine Response

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2007

Conditions
Healthy
Interventions
DRUG

Citalopram

40 mg, pill, single dose

DRUG

Escitalopram

20 mg, pill, single dose

DRUG

Dexamethasone

1 mg, pill, single dose

BEHAVIORAL

Cold Pressor Test

single test

Trial Locations (1)

K7L 4X3

Providence Centre, Mental Health Services, Kingston

All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

lead

Queen's University

OTHER

NCT00150527 - Specific Effects of Escitalopram on Neuroendocrine Response | Biotech Hunter | Biotech Hunter